The COVID-19 Therapeutics Roadmap

Research Progress
Updated: May 6, 2020

As part of our commitment to promoting healthy lifespans and our Lifespan Heroes, we have created the COVID-19 Therapeutics Roadmap to track the development of potentially life-saving treatments against the novel coronavirus.

This database aims to present preclinical and clinical trials on one easy-to-read page. We have divided the treatments into their corresponding types (vaccines, antivirals, antibody and cell therapies, and a range of repurposed therapies). Each entry contains basic information about a treatment and links to relevant scientific articles and its trial page on an official registry, such as clinicaltrials.gov. The database is in its early stage and will be updated on a regular basis, offering the most up-to-date overview of the COVID-19 treatment landscape.

The COVID-19 Therapeutics Roadmap is a crowdsourced project. If you are an active researcher, you are welcome to send suggestions regarding new entries to Elena Milova. For more information on the clinical trial process, check out this article, which explains what the phases mean. Stay healthy and wash your hands!

Table legend
1 2 3 4 5 6
Preclinical in vitro Preclinical in vivo Phase 1 Phase 2 Phase 3 Phase 4

Scientific Contributors:

Sedeer el-Showk, PhD (Lifespan.io)

Project Initiator:

Elena Milova (Lifespan.io)

Change Log

May 6: Celularity Inc. NK cells added

May 6: CytoDyn Inc. leronlimab study added

May 6: Entos DNA vaccine added

April 10: Massachusetts General Hospital hydroxychloroquine study added

April 9: COVID-19 Therapeutics Roadmap launched